Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GS143 is a selec-tive IκBα ubiquitination inhibitor with an IC50 of 5.2 μM for SCFβTrCP1-mediated IκBα ubiquitylation. GS143 sup-presses NF-κB acti-va-tion and tran-scrip-tion of tar-get genes and does not inhibit proteasome activity. GS143 has anti-asthma effect
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 38.00 | |
2 mg | In stock | $ 54.00 | |
5 mg | In stock | $ 89.00 | |
10 mg | In stock | $ 140.00 | |
25 mg | In stock | $ 288.00 | |
50 mg | In stock | $ 455.00 | |
100 mg | In stock | $ 677.00 | |
500 mg | In stock | $ 1,430.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 91.00 |
Description | GS143 is a selec-tive IκBα ubiquitination inhibitor with an IC50 of 5.2 μM for SCFβTrCP1-mediated IκBα ubiquitylation. GS143 sup-presses NF-κB acti-va-tion and tran-scrip-tion of tar-get genes and does not inhibit proteasome activity. GS143 has anti-asthma effect |
Targets&IC50 | IκBα phosphorylation:5.2 μM |
Synonyms | GS-143, GS 143 |
Molecular Weight | 466.46 |
Formula | C28H19FN2O4 |
CAS No. | 916232-21-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 40 mg/mL (85.75 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GS143 916232-21-8 NF-Κb Ubiquitination IκB/IKK E1/E2/E3 Enzyme NF-κB E2 conjugating enzyme inhibit IκBα Th2 Ubiquitin conjugating enzyme Ubiquitin ligase IL-4 IκB kinase βTrCP1 Nuclear factor-kappaB eosinophil Ubiquitin activating enzyme Nuclear factor-κB I kappa B kinase E3 ligating enzyme GS-143 IKK E1 activating enzyme anti-asthma ubiquitination Inhibitor airway GS 143 inflammation inhibitor